China’s robotics race is often described through videos: robot dogs climbing stairs, humanoids walking across stages, factory arms moving with machine precision. But the more important story may be happening in finance.
Xinhua and China Daily reported on 1 June that Hangzhou-based Unitree has moved into a fast IPO review process for Shanghai’s STAR Market. The detail matters because robotics is no longer just a laboratory or demonstration field. It is becoming a capital-market test: can China turn impressive hardware into companies that scale, export and survive?
Why Unitree matters
Unitree is one of China’s most visible robotics companies, known internationally for quadruped robots and, increasingly, humanoid systems. Its products sit at the intersection of motors, sensors, batteries, control systems, AI software and manufacturing quality. That makes it a useful proxy for the wider “embodied AI” sector, where intelligence is not only inside a chatbot but inside a machine that moves through the world.
The STAR Market was designed for technology companies. A rapid review process suggests policymakers and exchanges see robotics as strategically important, but market enthusiasm is not the same as commercial certainty.
The gap between demo and deployment
Robotics has always had a spectacle problem. A machine can look astonishing in a controlled video yet struggle in a messy warehouse, hospital corridor or home. Commercial deployment requires reliability, safety, maintenance networks, software updates, insurance, user training and predictable costs.
For humanoid robots in particular, the hardest question is not whether they can move. It is whether they can deliver enough useful labour to justify the price and complexity. Industrial robots already do repetitive tasks well. Humanoid robots must prove they can operate in environments designed for humans without becoming expensive novelties.
Capital can accelerate and distort
Public-market access can help robotics companies fund manufacturing, talent and international expansion. It can also create pressure to overpromise. Investors like big narratives: AI, automation, demographic change, labour shortages, national technology leadership. Robotics offers all of them.
The risk is that capital markets reward a company for the story before the product economics are mature. That risk is not unique to China. The United States, Japan, South Korea and Europe have all seen robotics cycles move from excitement to disappointment and back again.
Why this is a China story
China has three advantages in robotics: manufacturing depth, a large domestic industrial market and a policy environment that can coordinate funding, supply chains and demonstration projects. It also has fierce competition, thin hardware margins and export scrutiny in sensitive technologies.
Unitree’s IPO path will therefore be watched for more than valuation. It will signal how investors price China’s embodied-AI ambitions and how regulators balance support for strategic technology with the discipline public markets are supposed to impose.
The question to ask
The robotics race is not just “who has the coolest machine?” It is “who can build a company that sells useful machines at scale, services them reliably and improves them over time?”
Unitree’s move toward the STAR Market suggests China believes the answer will come not only from labs and factories, but from capital markets. That makes the IPO process a technology story, an industrial-policy story and a financial story at once.
